Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 1778-1782, April 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glatt, H.
Right arrow Articles by Grover, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glatt, H.
Right arrow Articles by Grover, P. L.

Influence of the Alkyl Substituent on Mutagenicity and Covalent DNA Binding of Bay Region Diol-Epoxides of 7-Methyl- and 7-Ethylbenz(a)anthracene in Salmonella and V79 Chinese Hamster Cells1

Hansruedi Glatt2, Ronald G. Harvey, David H. Phillips, Alan Hewer and Philip L. Grover

Department of Toxicology of the University, Obere Zahlbacher Strasse 67, D-6500 Mainz, Federal Republic of Germany [H. G.]; Ben May Institute, University of Chicago, Chicago, Illinois 60637 [R. G. H.]; and Chester Beatty Laboratories, Institute of Cancer Research, Fulham Road, London, SW3 6JB, England [D. H. P., A. H., P. L. G.]

The anti-isomers of the bay region diol-epoxides of the strong carcinogen 7-methylbenz(a)anthracene and of the weak carcinogen 7-ethylbenz(a)anthracene were investigated for mutagenicity in Salmonella typhimurium (reversion of the his- strains TA98 and TA100 to prototrophy) and V79 Chinese hamster cells (acquisition of resistance to 6-thioguanine and ouabain; formation of micronuclei). In addition, in the V79 cells, the levels of the DNA adducts formed were determined by 32P-postlabeling analysis. In terms of mutations per nmol compound administered, the methyl derivative was four to 10 times more potent, depending on the genetic endpoint, than its ethyl congener. However, when the results were expressed as mutations per adduct, the difference between the two diol-epoxides was small. Therefore, a higher level of DNA modification appears to be the major reason for the stronger mutagenicity of the methyl derivative. However, both diol-epoxides had similar half-lives (about 9 min) in physiological buffer, as determined from the decline in mutagenic activity after preincubation of the test compound. These results suggest that the effect of the 7-alkyl group on the extent of reaction with DNA is more a result of steric factors than of a change in the intrinsic chemical reactivity of the diol-epoxides.

1 This work was supported by the Deutsche Forschungsgemeinschaft (SFB-302), by a grant (CA-36097) from the National Cancer Institute to R. G. H., and by grants to the Institute of Cancer Research by the Medical Research Council and the Cancer Research Campaign.

2 To whom requests for reprints should be addressed.

Received 9/19/88. Revised 12/28/88. Accepted 1/ 5/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.